NUC-101

N/A

Report date: 2025/01/26 16:31:52
NME

Base Information

Drug NameNUC-101
Drug Alias NameNUC-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtivesSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNucorion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNucorion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A